InterCure Ltd. (INCR)

InterCure Statistics

Total Valuation

InterCure has a market cap or net worth of $79.09 million. The enterprise value is $118.75 million.

Market Cap	79.09M
Enterprise Value	118.75M

Important Dates

The last earnings date was Wednesday, October 8, 2025, before market open.

Earnings Date	Oct 8, 2025
Ex-Dividend Date	n/a

Share Statistics

InterCure has 54.51 million shares outstanding. The number of shares has increased by 8.85% in one year.

Current Share Class	54.51M
Shares Outstanding	54.51M
Shares Change (YoY)	+8.85%
Shares Change (QoQ)	+29.17%
Owned by Insiders (%)	36.44%
Owned by Institutions (%)	6.01%
Float	34.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.10
Forward PS	0.37
PB Ratio	0.62
P/TBV Ratio	1.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.41.

Current Ratio	1.85
Quick Ratio	1.08
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.41

Financial Efficiency

Return on equity (ROE) is -16.68% and return on invested capital (ROIC) is -9.43%.

Return on Equity (ROE)	-16.68%
Return on Assets (ROA)	-7.74%
Return on Invested Capital (ROIC)	-9.43%
Return on Capital Employed (ROCE)	-16.81%
Revenue Per Employee	$225,495
Profits Per Employee	-$65,789
Employee Count	320
Asset Turnover	0.33
Inventory Turnover	1.47

Taxes

Income Tax	-4.90M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.65% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.65%
50-Day Moving Average	1.57
200-Day Moving Average	1.55
Relative Strength Index (RSI)	36.54
Average Volume (20 Days)	37,814

Short Selling Information

The latest short interest is 10,301, so 0.02% of the outstanding shares have been sold short.

Short Interest	10,301
Short Previous Month	24,304
Short % of Shares Out	0.02%
Short % of Float	0.03%
Short Ratio (days to cover)	0.08

Income Statement

In the last 12 months, InterCure had revenue of $72.16 million and -$21.05 million in losses. Loss per share was -$0.42.

Revenue	72.16M
Gross Profit	12.05M
Operating Income	-27.42M
Pretax Income	-27.04M
Net Income	-21.05M
EBITDA	-23.93M
EBIT	-27.42M
Loss Per Share	-$0.42

Balance Sheet

The company has $15.31 million in cash and $53.23 million in debt, giving a net cash position of -$37.92 million or -$0.70 per share.

Cash & Cash Equivalents	15.31M
Total Debt	53.23M
Net Cash	-37.92M
Net Cash Per Share	-$0.70
Equity (Book Value)	128.29M
Book Value Per Share	2.25
Working Capital	51.06M

Cash Flow

In the last 12 months, operating cash flow was -$3.34 million and capital expenditures -$2.16 million, giving a free cash flow of -$5.69 million.

Operating Cash Flow	-3.34M
Capital Expenditures	-2.16M
Free Cash Flow	-5.69M
FCF Per Share	-$0.10

Margins

Gross margin is 16.71%, with operating and profit margins of -38.01% and -29.18%.

Gross Margin	16.71%
Operating Margin	-38.01%
Pretax Margin	-37.47%
Profit Margin	-29.18%
EBITDA Margin	-33.16%
EBIT Margin	-38.01%
FCF Margin	n/a

Dividends & Yields

InterCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.85%
Shareholder Yield	-8.85%
Earnings Yield	-26.62%
FCF Yield	-7.19%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

InterCure has an Altman Z-Score of 0.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.21
Piotroski F-Score	2